Blog
RSS FeedPosted by Michael Wonder on 25 May 2021
Dupixent (dupilumab) now publicly reimbursed in Ontario and New Brunswick for the treatment of moderate to severe atopic dermatitis
25 May 2021 - Dupixent is the only biologic medicine approved by Health Canada to treat moderate to severe atopic dermatitis. ...
Posted by Michael Wonder on 29 Apr 2021
Valeo Pharma’s Redesca and Redesca HP to be covered under the Ontario Public Drug Benefit Program
28 April 2021 - Additional provincial coverage expected to follow. ...
Posted by Michael Wonder on 12 Feb 2020
Quebec, New Brunswick, Newfoundland, Nova Scotia and Manitoba join Alberta, Saskatchewan, in adding Knight’s Probuphine to their provincial drug plans in the fight against the opioid crisis
11 February 2020 - Probuphine is also listed for reimbursement through the Non-Insured Health Benefit (NIHB) and Veteran Affairs Canada drug ...
Posted by Michael Wonder on 04 Dec 2019
B.C. wants federal health funding lift before national pharmacare program
3 December 2019 - B.C. wants more money from Ottawa for health care before a national pharmacare program is created, ...
Posted by Michael Wonder on 04 Sep 2019
NDP promises to restore special drugs program
4 September 2019 - Province paid deductible for chronic patients from 1968 to 2018. ...
Posted by Michael Wonder on 14 Feb 2019
Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade
13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...
Posted by Michael Wonder on 11 Dec 2018
Glatect added to public drug plan in British Columbia as sole RRMS treatment of its type
11 December 2018 - Pendopharm’s Glatect (glatiramer acetate) — a treatment for patients with relapsing-remitting multiple sclerosis — has been added ...
Posted by Michael Wonder on 04 Dec 2018
Enstilar is now covered by the Alberta Drug Benefit List for adults with psoriasis vulgaris
3 December 2018 - Leo Pharma Canada has announced that as of 1 December 2018, Enstilar has been added as ...
Posted by Michael Wonder on 21 Mar 2018
Activists urge Ottawa to fund $1-million treatment for rare disease
20 March 2018 - Carrying placards and chanting “Cure SMA” and “Spinraza for all,” a group of health care activists ...
Posted by Michael Wonder on 30 Nov 2017
New report reveals need for a gender-based approach to health funding for women to have full economic empowerment
30 November 2017 - Recent CADTH recommendation to improve access to oral uterine fibroids treatment presents positive step forward in helping ...
Posted by Michael Wonder on 19 Jan 2017
Canada reaches health funding agreement with Saskatchewan
17 January 2017 - Canada's public healthcare system is a source of pride. The Government of Canada and the Government ...
Posted by Michael Wonder on 10 Jan 2017
The real health-care change we need? Strong leadership
10 January 2017 - Saskatchewan has announced that it will scrap its 12 health regions and create a single health ...
Posted by Michael Wonder on 04 Jan 2017
Provinces seek end to health-funding standoff with Ottawa
3 January 2017 - Finance and health ministers in the provinces and territories that have refused the federal government’s offer ...
Posted by Michael Wonder on 20 Dec 2016
Liberals fail to clinch 10-year health deal with provinces
19 December 2016 - Prime Minister Justin Trudeau’s campaign vow to improve federal-provincial relations has suffered a major blow as ...
Posted by Michael Wonder on 18 Oct 2016
Ottawa won’t boost provincial health transfers without reform plan: Philpott
16 October 2016 - The federal Health Minister says Ottawa has been giving large sums of money to the provinces ...